{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:47:41Z","timestamp":1791326861494,"version":"4.3.1"},"reference-count":134,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["21-75-30020"],"award-info":[{"award-number":["21-75-30020"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cathepsin K (CatK) is a part of the family of cysteine proteases involved in many important processes, including the degradation activity of collagen 1 and elastin in bone resorption. Changes in levels of CatK are associated with various pathological conditions, primarily related to bone and cartilage degradation, such as pycnodysostosis (associated with CatK deficiency), osteoporosis, and osteoarthritis (associated with CatK overexpression). Recently, the increased secretion of CatK is being highly correlated to vascular inflammation, hypersensitivity pneumonitis, Wegener granulomatosis, berylliosis, tuberculosis, as well as with tumor progression. Due to the wide spectrum of diseases in which CatK is involved, the design and validation of active site-specific inhibitors has been a subject of keen interest in pharmaceutical companies in recent decades. In this review, we summarized the molecular background of CatK and its involvement in various diseases, as well as its clinical significance for diagnosis and therapy.<\/jats:p>","DOI":"10.3390\/ijms232213762","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T02:44:32Z","timestamp":1667961872000},"page":"13762","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives"],"prefix":"10.3390","volume":"23","author":[{"given":"Olja","family":"Mijanovi\u0107","sequence":"first","affiliation":[{"name":"Dia-M, LCC, 7 b.3 Magadanskaya Str., 129345 Moscow, Russia"},{"name":"The Human Pathology Department, Sechenov First Moscow State University, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Jakovleva","sequence":"additional","affiliation":[{"name":"HoxLife Science GmbH, Gutleutstra\u00dfe 169-171, 60327 Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Brankovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Forensics Engineering, University of Criminal Investigation and Police Studies, Cara Dusana 196, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Zdravkova","sequence":"additional","affiliation":[{"name":"AD Alkaloid Skopje, Boulevar Alexander the Great 12, 1000 Skopje, North Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Pualic","sequence":"additional","affiliation":[{"name":"Institute Cardiovascular Diseases Dedinje, Heroja Milana Tepica 1, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana A.","family":"Belozerskaya","sequence":"additional","affiliation":[{"name":"Bach Institute of Biochemistry, Research Center of Biotechnology, Russian Academy of Sciences, 119071 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina I.","family":"Nikitkina","sequence":"additional","affiliation":[{"name":"ArhiMed Clinique for New Medical Technologies, Vavilova St. 68\/2, 119261 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0985-6545","authenticated-orcid":false,"given":"Alessandro","family":"Parodi","sequence":"additional","affiliation":[{"name":"Scientific Center for Translation Medicine, Sirius University of Science and Technology, 354340 Sochi, Russia"},{"name":"Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3046-4565","authenticated-orcid":false,"suffix":"Jr.","given":"Andrey A.","family":"Zamyatnin","sequence":"additional","affiliation":[{"name":"Scientific Center for Translation Medicine, Sirius University of Science and Technology, 354340 Sochi, Russia"},{"name":"Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia"},{"name":"Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia"},{"name":"Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7X, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"ref_1","unstructured":"(2022, October 08). MEROPS\u2014The Pepotidase Database. EMBL-EBI. Available online: https:\/\/www.ebi.ac.uk\/merops\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1093\/hmg\/ddu309","article-title":"Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding genes","volume":"23","author":"Ezkurdia","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/bs.acc.2014.12.004","article-title":"Biofluid proteases profiling in diabetes mellitus","volume":"69","author":"Trindade","year":"2015","journal-title":"Adv. Clin. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1196\/annals.1346.018","article-title":"The regulation of cathepsin K gene expression","volume":"1068","author":"Troen","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1074\/mcp.R800012-MCP200","article-title":"Metadegradomics: Toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome","volume":"7","author":"Doucet","year":"2008","journal-title":"Mol. Cell. Proteom."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1083\/jcb.31.2.319","article-title":"Lysosome function in the regulation of the secretory process in cells of the anterior pituitary gland","volume":"1","author":"Smith","year":"1966","journal-title":"J. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1242\/jcs.091181","article-title":"Lysosomal cell death at a glance","volume":"126","author":"Aits","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tcb.2010.12.002","article-title":"Proteolytic networks in cancer","volume":"21","author":"Mason","year":"2011","journal-title":"Trends. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc1949","article-title":"Cysteine cathepsins: Mulfunctional enzymes in cancer","volume":"6","author":"Mohamed","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0002-9440(10)63777-7","article-title":"Pivotal role of cathepsin K in lung fibrosis","volume":"164","author":"Brasch","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biochi.2007.08.011","article-title":"Biochemical properties and regulation of cathepsin K activity","volume":"90","author":"Lecaille","year":"2008","journal-title":"Biochimie"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2015.08.010","article-title":"Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression","volume":"35","author":"Lah","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/14756366.2018.1465417","article-title":"Advances in the discovery of cathepsin K inhibitors on bone resorption","volume":"33","author":"Lu","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/13543776.2022.2040480","article-title":"A patent review on cathepsin K inhibitors to treat osteoporosis (2011\u20132021)","volume":"32","author":"Rocho","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1074\/jbc.M310349200","article-title":"Regulation of collagenase activities of human cathepsins by glycosaminoglycans","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/BJ20100337","article-title":"Conformational flexibility and allosteric regulation of cathepsin K","volume":"429","author":"Novinec","year":"2010","journal-title":"Biochem. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13955","DOI":"10.1074\/jbc.272.21.13955","article-title":"Autocatalytic activation of human cathepsin K","volume":"272","author":"McQueney","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Yadati, T., Houben, T., Bitorina, A., and Shiri-Sverdlov, R. (2020). The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management. Cells, 9.","DOI":"10.3390\/cells9071679"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Calio, A., Brunelli, M., Gobbo, S., Argani, P., Munari, E., Netto, G., and Martignoni, G. (2021). Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors. Cancers, 13.","DOI":"10.3390\/cancers13102441"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1097-4644(19990201)72:2<251::AID-JCB9>3.0.CO;2-W","article-title":"Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors","volume":"72","author":"Shalhoub","year":"1997","journal-title":"J. Cell Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gene.2007.08.007","article-title":"AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells","volume":"403","author":"Pang","year":"2007","journal-title":"Gene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/154405910608500703","article-title":"Bone remodeling in post-menopausal osteoporosis","volume":"85","author":"Lerner","year":"2006","journal-title":"J Dent Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S8756-3282(01)00420-3","article-title":"Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture","volume":"28","author":"Komine","year":"2001","journal-title":"Bone"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"45969","DOI":"10.1074\/jbc.M408795200","article-title":"Essential role of p38 mitogen-activated protein kinase n cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1","volume":"279","author":"Matsumoto","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.1074\/jbc.M111696200","article-title":"Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling","volume":"277","author":"Mansky","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ajhg.2016.11.004","article-title":"Biallelic Mutations in MITF Cause Coloboma, Osteopetrosis, Microphthalmia, Macrocephaly, Albinism, and Deafness","volume":"99","author":"George","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1073\/pnas.091479298","article-title":"Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family","volume":"98","author":"Motyckova","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/bj3090721","article-title":"Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K\/OC-2","volume":"309","author":"Saneshige","year":"1995","journal-title":"Biochem. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1271\/bbb.64.1771","article-title":"Preliminary communication. MRNA expression of MT1-MMP, MMP-9, cathepsin K, and TRAP in highly enriched osteoclasts cultured on several matrix proteins and ivory surfaces","volume":"64","author":"Uemura","year":"2000","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-291X(02)00179-1","article-title":"Osteoprotegerin differentially regulates protease expression in osteoclasts cultures","volume":"293","author":"Wittrant","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1006\/bbrc.1996.0947","article-title":"Mammalian mature osteoclasts as estrogen target cells","volume":"223","author":"Mano","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/00220345010800011001","article-title":"Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation","volume":"80","author":"Kamolmatyakul","year":"2001","journal-title":"J. Dent. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"108052","DOI":"10.1016\/j.celrep.2020.108052","article-title":"Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption","volume":"32","author":"Cawley","year":"2020","journal-title":"Cell Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fcell.2020.00433","article-title":"Cathepsin K: The actionin and beyond bone","volume":"8","author":"Dai","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"108153","DOI":"10.1016\/j.jmgm.2022.108153","article-title":"In silico and in vitro mapping of specificity patterns of glycosaminoglycans towards cysteine cathepsins B, L, K, S and V","volume":"113","author":"Bojarski","year":"2022","journal-title":"J. Mol. Graph. Model."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.pep.2011.11.002","article-title":"A simple and efficient protocol for the production of recombinant cathepsin V and other cysteine cathepsins in soluble form in Escherichia coli","volume":"82","author":"Novinec","year":"2012","journal-title":"Protein Expr. Purif."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/er.2015-1114","article-title":"Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned","volume":"38","author":"Drake","year":"2017","journal-title":"Endocr. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00432-019-02950-y","article-title":"Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone","volume":"145","author":"Liang","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1515\/BC.2003.100","article-title":"Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation","volume":"384","author":"Hou","year":"2003","journal-title":"Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"116499","DOI":"10.1016\/j.bone.2022.116499","article-title":"Mechanisms of bone resorption","volume":"163","author":"Everts","year":"2022","journal-title":"Bone"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"17474","DOI":"10.1073\/pnas.1414126111","article-title":"Structural basis of collagen fiber degradation by cathepsin K","volume":"111","author":"Aguda","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-007-9091-4","article-title":"Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model","volume":"82","author":"Rissanen","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.abb.2014.07.034","article-title":"Bone tissue remodeling and development: Focus on matrix metalloproteinase functions","volume":"561","author":"Paiva","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0002-9440(10)64050-3","article-title":"Putative role for cathepsin K in degradation of AA and AL amyloidosis","volume":"158","author":"Stix","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/1566524023362401","article-title":"Pycnodysostosis: Role and regulation of cathepsin K in osteoclast function and human disease","volume":"2","author":"Motyckova","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/jbmr.3227","article-title":"An Ectosteric Inhibitor of cathepsin K Inhibits Bone Resorption in Ovariectomized Mice","volume":"32","author":"Panwar","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Blau, N., Dionisi Vici, C., Ferreira, C.R., Vianey-Saban, C., and van Karnebeek, C.D.M. (2022). Mucolipidoses, Multiple Sulfatase Deficiency, and Cathepsin K and C Deficiency. Physician\u2019s Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases, Springer.","DOI":"10.1007\/978-3-030-67727-5"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e13058","DOI":"10.1111\/cpr.13058","article-title":"Cathepsin K deficiency promotes alveolar bone regeneration by promoting jaw bone marrow mesenchymal stem cells proliferation and differentiation via glycolysis pathway","volume":"54","author":"Zhang","year":"2021","journal-title":"Cell Prolif."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/17425247.2020.1783234","article-title":"The perspectives of intra-articular therapy in the management of osteoarthritis","volume":"17","author":"Migliore","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Khoshdel, A., Forootan, M., Afsharinasab, M., Rezaian, M., and Abbasifard, M. (2022). Assessment of the circulatory concentrations of cathepsin D, cathepsin K, and alpha-1 antitrypsin in patients with knee osteoarthritis. Ir. J. Med. Sci.","DOI":"10.1007\/s11845-022-03061-3"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8666","DOI":"10.1002\/jcp.26745","article-title":"Articular cartilage protection in Ctsk\u2212\/\u2212 mice is associated with cellular and molecular changes in subchondral bone and cartilage matrix","volume":"233","author":"Soki","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2016.04.010","article-title":"Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy","volume":"117","author":"Mukherjee","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40620-020-00801-5","article-title":"Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients","volume":"34","author":"Bolignano","year":"2020","journal-title":"J. Nephrol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejmhg.2015.02.001","article-title":"Cytokines in Gaucher disease: Role in the pathogenesis of bone and pulmonary disease","volume":"16","author":"Tantawy","year":"2015","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/jid.2008.63","article-title":"Cathepsin K in melanoma invasion","volume":"128","author":"Codriansky","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1038\/ncomms4838","article-title":"Cathepsin K-mediated Notch1 activation contributes to neovascularization in response to hypoxia","volume":"5","author":"Jiang","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6938620","DOI":"10.1155\/2020\/6938620","article-title":"Cathepsin K Deficiency Impaired Ischemia-Induced Neovascularization in Aged Mice","volume":"2020","author":"Yue","year":"2020","journal-title":"Stem Cells Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3349\/ymj.2014.55.4.912","article-title":"Increased serum cathepsin K in patients with coronary artery disease","volume":"55","author":"Li","year":"2014","journal-title":"Yonsei Med. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1038\/s41598-017-09037-z","article-title":"Cathepsin K knockout protects against cardiac dysfunction in diabetic mice","volume":"7","author":"Guo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e133019","DOI":"10.1172\/jci.insight.133019","article-title":"Inappropriate cathepsin K secretion promotes its enzymatic activation driving heart and valve malformation","volume":"5","author":"Lu","year":"2020","journal-title":"JCI Insight"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5551\/jat.RV17016","article-title":"Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases","volume":"25","author":"Wu","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/jcmm.14016","article-title":"Endogenous reduction of miR-185 accelerates cardiac function recovery in mice following myocardial infarction via targeting of cathepsin K","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_65","first-page":"4805","article-title":"Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation","volume":"190","author":"Hirai","year":"2013","journal-title":"Immunology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10571-019-00682-8","article-title":"Cathepsin K knockout exacerbates haemorrhagic transformation induced by recombinant tissue plasminogen activator after focal cerebral ischaemia in mice","volume":"39","author":"Zhao","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1161\/STROKEAHA.107.513648","article-title":"Cathepsin B, K, and S Are Expressed in Cerebral Aneurysms and Promote the Progression of Cerebral Aneurysms","volume":"39","author":"Aoki","year":"2008","journal-title":"Stroke"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1161\/ATVBAHA.108.178160","article-title":"Cathepsin K and Metabolic Abnormalities in Schizophrenia","volume":"28","author":"Bernstein","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/syn.20358","article-title":"Cathepsin K and schizophrenia","volume":"61","author":"Bernstein","year":"2007","journal-title":"Synapse"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1346-8138.14112","article-title":"Mouse models of psoriasis and their relevance","volume":"45","author":"Nakajima","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbamcr.2016.12.021","article-title":"Cathepsin K cleavage of SDF-1\u03b1 inhibits its chemotactic activity towards glioblastoma stem-like cells","volume":"1864","author":"Hira","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.2174\/0929867326666190730113123","article-title":"Osteoporosis: Current and Emerging Therapies Targeted to Immunological Checkpoints","volume":"27","author":"Sirufo","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.3390\/curroncol29080471","article-title":"Cathepsin K: A Versatile Potential Biomarker and Therapeutic Target for Various Cancers","volume":"29","author":"Qian","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1158\/1078-0432.CCR-08-0732","article-title":"Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression","volume":"17","author":"Kleer","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9440(10)63323-8","article-title":"Cathepsin K is the principal protease in giant cell tumor of bone","volume":"165","author":"Lindeman","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mc.20362","article-title":"Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis","volume":"73","author":"Husmann","year":"2008","journal-title":"Mol. Carcinog."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/his.12059","article-title":"Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): A clinicopathological study emphasizing extrarenal PEComas","volume":"62","author":"Rao","year":"2013","journal-title":"Histopatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1111\/j.1468-3083.2011.04436.x","article-title":"cathepsin K expression in basal cell carcinoma","volume":"27","author":"Ishida","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Bitu, C.C., Kauppila, J.H., Bufalino, A., Nurmenniemi, S., Teppo, S., Kein\u00e4nen, M., Vilen, S.-T., Lehenkari, P., Nyberg, P., and Coletta, R.D. (2013). Cathepsin K is present in invasive oral tongue squamous cell carcinoma in vivo and in vitro. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070925"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1158\/0008-5472.CAN-20-3251","article-title":"The CD200-CD200R axis promotes squamous cell carcinoma","volume":"81","author":"Khan","year":"2021","journal-title":"Cancer Res."},{"key":"ref_81","first-page":"5386","article-title":"The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma","volume":"57","author":"Bilbe","year":"1997","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1359\/jbmr.2003.18.2.222","article-title":"Cathepsin K mRNA and protein expression in prostate cancer progression","volume":"18","author":"Brubaker","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fonc.2020.00305","article-title":"CaSR Induces Osteoclast Differentiation and Promotes Bone Metastasis in Lung Adenocarcinoma","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1053\/hupa.2000.8448","article-title":"Expression of cathepsin K in chordoma","volume":"31","author":"Haeckel","year":"2000","journal-title":"Hum. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.5858\/arpa.2014-0385-RS","article-title":"Alveolar Soft Part Sarcoma","volume":"11","author":"Jaber","year":"2015","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_86","first-page":"4064","article-title":"Proteins involved in cutaneous basal cell carcinoma development","volume":"3","author":"Bednarski","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Reithmeier, A., Norg\u00e5rd, M., Ek-Rylander, B., N\u00e4reoja, T., and Andersson, G. (2020). Cathepsin K regulates localization and secretion of Tartrate-Resistant Acid Phosphatase (TRAP) in TRAP-overexpressing MDA-MB-231 breast cancer cells. BMC Mol. Cell Biol., 21.","DOI":"10.1186\/s12860-020-00253-6"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Andrade, S., Gouvea, I., Silva, M., Castro, E., de Paula, C., Okamoto, D., Oliveira, L., Peres, G., Ottaiano, T., and Facina, T. (2016). Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer\u2014Molecularly distinct behavior of cathepsin K in breast cancer. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2203-7"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41419-022-05215-8","article-title":"Cathepsin K regulates the tumor growth and metastasis by IL-17\/CTSK\/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"901647","DOI":"10.3389\/fonc.2022.901647","article-title":"Expression and clinical significance of Cathepsin K and MMPs in invasive non-functioning pituitary adenomas","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1359\/jbmr.2000.15.8.1477","article-title":"Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts","volume":"15","author":"Takeshita","year":"2000","journal-title":"J. Bone Miner Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2353\/ajpath.2009.080906","article-title":"Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis","volume":"175","author":"Podgorski","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/onc.2012.166","article-title":"Macrophage cathepsin K promotes prostate tumor progression in bone","volume":"32","author":"Herroon","year":"2013","journal-title":"Oncogene"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.ejhg.5200481","article-title":"Cathepsin K gene mutations and 1q21 haplotypes in at patients with pycnodysostosis in an outbred population","volume":"8","author":"Haagerup","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00223-015-9963-y","article-title":"A Mutation in CATK Gene in an Autosomal Recessive Pycnodysostosis Family of Chinese Origin","volume":"96","author":"Huang","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jor.23005","article-title":"Increased expression and activation of cathepsin K in human osteoarthritic cartilage and synovial tissues","volume":"34","author":"Kozawa","year":"2016","journal-title":"J. Orthop. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.febslet.2015.04.008","article-title":"Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role","volume":"589","author":"Hao","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5710340","DOI":"10.1155\/2019\/5710340","article-title":"Effects of the cathepsin K Inhibitor ONO-5334 and concomitant use of ONO-5334 with methotrexate on collagen-induced arthritis in cynomolgus monkeys","volume":"2019","author":"Yamada","year":"2019","journal-title":"Int. J. Rheumatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bonr.2018.05.006","article-title":"Effect of a cathepsin K inhibitor on arthritis and bone mineral density in ovariectomized rats with collagen-induced arthritis","volume":"9","author":"Yamashita","year":"2018","journal-title":"Bone Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1465-9921-12-72","article-title":"The effect of cathepsin K deficiency on airway development and TGF-beta1 degradation","volume":"12","author":"Zhang","year":"2011","journal-title":"Respir. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00428-018-2325-1","article-title":"Cathepsin K expression in clear cell \u201csugar\u201d tumor (PEComa) of the lung","volume":"473","author":"Calio","year":"2018","journal-title":"Virchows Arch."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/modpathol.2008.189","article-title":"Cathepsin-K expression in pulmonary lymphangioleiomyomatosis","volume":"22","author":"Chilosi","year":"2009","journal-title":"Mod. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"H1479","DOI":"10.1152\/ajpheart.00954.2006","article-title":"Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis","volume":"292","author":"Platt","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Funicello, M., Novelli, M., Ragni, M., Vottari, T., Cocuzza, T., Soriano-Lopez, J., Chiellini, C., Boschi, F., Marzola, P., and Masiello, P. (2007). Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000683"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/ATVBAHA.108.172320","article-title":"Deficiency and Inhibition of cathepsin K Reduce Body Weight Gain and Increase Glucose Metabolism in Mice","volume":"28","author":"Yang","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuint.2009.01.011","article-title":"Cathepsin K generates enkephalin from beta-endorphin: A new mechanism with possible relevance for schizophrenia","volume":"54","author":"Lendeckel","year":"2009","journal-title":"Neurochem. Int."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jocn.2017.08.021","article-title":"Role of cathepsin K in the development of chronic subdural hematoma","volume":"45","author":"Tsutsumi","year":"2017","journal-title":"Clin. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"14249","DOI":"10.1073\/pnas.94.26.14249","article-title":"Design of potent and selective human cathepsin K inhibitors that span the active site","volume":"94","author":"Thompson","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Law, S., Panwar, P., Li, J., Aguda, A.H., Jamroz, A., Guido, R.V.C., and Br\u00f6mme, D. (2017). A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186869"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1517\/13543780902832661","article-title":"Cathepsin K inhibitors for osteoporosis and potential off-target effects","volume":"18","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12967-018-1497-4","article-title":"Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711","volume":"16","author":"Rizoska","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00223-009-9279-x","article-title":"Treatment with a potent cathepsin K inhibitor preserves cortical and trabecular bone mass in ovariectomized monkeys","volume":"85","author":"Stroup","year":"2009","journal-title":"Calcif. Tissue Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1007\/s00198-011-1529-x","article-title":"Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys","volume":"22","author":"Jerome","year":"2011","journal-title":"Osteoporos. Int."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jbmr.1475","article-title":"Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys","volume":"27","author":"Masarachia","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11033-020-05951-0","article-title":"Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro","volume":"48","author":"Vashum","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41388-021-02088-7","article-title":"Inhibition of cathepsin K sensitizes oxaliplatin-induced apoptotic cell death by Bax upregulation through OTUB1-mediated p53 stabilization in vitro and in vivo","volume":"41","author":"Seo","year":"2022","journal-title":"Oncogene"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1759720X13490860","article-title":"Odanacatib in postmenopausal women with low bone mineral density: A review of current clinical evidence","volume":"5","author":"Zerbini","year":"2013","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00198-013-2398-2","article-title":"Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis\u2014A double-blind, randomized, dose-finding study","volume":"25","author":"Nakamura","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.1695","article-title":"Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study","volume":"27","author":"Langdahl","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00198-014-2944-6","article-title":"Odanacatib for the treatment of postmenopausal osteoporosis: Development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial","volume":"26","author":"Bone","year":"2015","journal-title":"Osteoporos. Int."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3816\/CBC.2010.n.059","article-title":"The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: Results of a 4-week, double-blind, randomized, controlled trial","volume":"10","author":"Jensen","year":"2010","journal-title":"Clin. Breast Cancer."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"172382","DOI":"10.1016\/j.ejphar.2019.05.011","article-title":"A novel derivative of artemisinin inhibits cell proliferation and metastasis via down-regulation of cathepsin K in breast cancer","volume":"858","author":"Gu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/14756366.2021.2024527","article-title":"Highly potent inhibitors of cathepsin K with a differently positioned cyanohydrazide warhead: Structural analysis of binding mode to mature and zymogen-like enzymes","volume":"37","author":"Brynda","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0022034512468757","article-title":"Inhibiting periapical lesions through AAV-RNAi silencing of cathepsin K","volume":"92","author":"Gao","year":"2013","journal-title":"J. Dent. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/jre.12345","article-title":"The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation","volume":"51","author":"Chen","year":"2016","journal-title":"J. Periodontal. Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e00498-20","DOI":"10.1128\/IAI.00498-20","article-title":"Inhibition of Cathepsin K Alleviates Autophagy-Related Inflammation in Periodontitis-Aggravating Arthritis","volume":"88","author":"Yue","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.jid.5700535","article-title":"Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation","volume":"127","author":"Bhawan","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2008.10.036","article-title":"Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo","volume":"44","author":"Kozloff","year":"2009","journal-title":"Bone"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Ranade, H., Paliwal, P., Chaudhary, A.A., Piplani, S., Rudayni, H.A., Al-Zharani, M., Niraj, R.R., and Datta, M. (2021). Predicting Diagnostic Potential of Cathepsin in Epithelial Ovarian Cancer: A Design Validated by Computational, Biophysical and Electrochemical Data. Biomolecules, 12.","DOI":"10.3390\/biom12010053"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"100223","DOI":"10.1016\/j.mtbio.2022.100223","article-title":"Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment","volume":"14","author":"Zhang","year":"2022","journal-title":"Mater. Today Bio"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11255-020-02602-y","article-title":"Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients","volume":"53","author":"Bolignano","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00380-014-0570-z","article-title":"Impact of circulating cathepsin K on the coronary calcification and the clinical outcome in chronic kidney disease patients","volume":"31","author":"Izumi","year":"2016","journal-title":"Heart Vessel."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41413-021-00178-6","article-title":"GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation","volume":"10","author":"Siddiqui","year":"2022","journal-title":"Bone Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/07391102.2020.1813630","article-title":"Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases","volume":"40","author":"Oso","year":"2022","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/22\/13762\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:12:55Z","timestamp":1760145175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/22\/13762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":134,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232213762"],"URL":"https:\/\/doi.org\/10.3390\/ijms232213762","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]}}}